* no consent. * symptoms for a period longer than 20 days. * not detectable by acid nuclear testing within 48 hours prior to elegibility. * descompensated congestive heart failure, in which receiving 500ml of intrasvascular volume signifies a life risk. * history of severe adverse events or anaphylaxis to plasma components

* no consent. * symptoms for a period longer than 20 days. * not detectable by acid nuclear testing within 48 hours prior to elegibility. * descompensated congestive heart failure, in which receiving 500ml of intrasvascular volume signifies a life risk. * history of severe adverse events or anaphylaxis to plasma components

- no consent. - symptoms for a period longer than 20 days. - not detectable by acid nuclear testing within 48 hours prior to elegibility. - descompensated congestive heart failure, in which receiving 500ml of intrasvascular volume signifies a life risk. - history of severe adverse events or anaphylaxis to plasma components

- no consent. - symptoms for a period longer than 20 days. - not detectable by acid nuclear testing within 48 hours prior to elegibility. - descompensated congestive heart failure, in which receiving 500ml of intrasvascular volume signifies a life risk. - history of severe adverse events or anaphylaxis to plasma components